Skip to main content
. Author manuscript; available in PMC: 2023 Mar 26.
Published in final edited form as: Clin Transplant. 2021 Feb 6;35(3):e14206. doi: 10.1111/ctr.14206

FIGURE 1.

FIGURE 1

Patients with high levels of dd-cfDNA ≥ 0.12 had higher percentage of bridge to transplant with LVAD (31 vs. 7.7%, p 0.028). dd-cfDNA—Donor-derived Cell-free DNA; LVAD—left ventricular assist device